Table 2.

Study endpoint.

	Usual-care (n = 74)	Nurse-led program (n = 76)
At baseline
FPG (mmol/L)	7.1 ± 1.3	7.0 ± 1.4
HbA1c (%)	6.8 ± 1.0	6.8 ± 1.1
HbA1c < 7.0%, n (%)	45 (60.8)	46 (60.5)
Antidiabetic drug, n (%)	74 (100)	76 (100)
uACR (mg/g)	15.6 (6.8–22.3)	16.4 (7.0–21.9)
At 6 mo’ follow-up
FPG (mmol/L)	7.2 ± 1.2	6.6 ± 1.1*
HbA1c (%)	6.9 ± 1.0	6.4 ± 1.1*
HbA1c < 7.0%, n (%)	44 (59.5)	50 (65.8)*
Antidiabetic drug, n (%)	71 (95.9)	76 (100)
uACR (mg/g)	22.3 (11.5–28.2)	17.2 (9.3–25.4)*
Microalbuminuria, n (%)	7 (9.5)	2 (2.6)*

FPG = fasting plasma glucose, HbA1c = glycated hemoglobin A1c, uACR = urine albumin creatinine ratio.

^*P < .05 versus the usual-care group.